Search Results - "Tselepis, A.D."

Refine Results
  1. 1

    Protease-activated receptor-1 antagonists in long-term antiplatelet therapy. Current state of evidence and future perspectives by Moschonas, I.C, Goudevenos, J.A, Tselepis, A.D

    Published in International journal of cardiology (15-04-2015)
    “…Abstract Atherothrombosis and its clinical manifestations are among the leading causes of death in the developed world. The current standard-of-care…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Persistence of an atherogenic lipid profile after treatment of acute infection with brucella by Apostolou, F., Gazi, I.F., Kostoula, A., Tellis, C.C., Tselepis, A.D., Elisaf, M., Liberopoulos, E.N.

    Published in Journal of lipid research (01-12-2009)
    “…Serum lipid changes during infection may be associated with atherogenesis. No data are available on the effect of Brucellosis on lipids. Lipid parameters were…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Biocatalytic preparation of acylated derivatives of flavonoid glycosides enhances their antioxidant and antimicrobial activity by Mellou, F., Lazari, D., Skaltsa, H., Tselepis, A.D., Kolisis, F.N., Stamatis, H.

    Published in Journal of biotechnology (30-03-2005)
    “…Enzymatic synthesis of acylated derivatives of a monosaccharidic flavonoid chrysoeriol-7- O-β- d-(3″- E- p-coumaroyl)-glucopyranoside as well as of a…”
    Get full text
    Journal Article
  9. 9

    The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome by Filippatos, T.D, Gazi, I.F, Liberopoulos, E.N, Athyros, V.G, Elisaf, M.S, Tselepis, A.D, Kiortsis, D.N

    Published in Atherosclerosis (01-08-2007)
    “…Abstract Background Increased concentration of small dense LDL cholesterol (sdLDL-C) and activity of lipoprotein-associated phospholipase A2 (Lp-PLA2 ) are…”
    Get full text
    Journal Article
  10. 10

    Acute infection with Epstein–Barr virus is associated with atherogenic lipid changes by Apostolou, F, Gazi, I.F, Lagos, K, Tellis, C.C, Tselepis, A.D, Liberopoulos, E.N, Elisaf, M

    Published in Atherosclerosis (01-10-2010)
    “…Abstract Objective To evaluate the effects of acute infection with Epstein–Barr virus (infectious mononucleosis, IM) on lipids and lipoproteins. Methods…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Use of ionic liquids as media for the biocatalytic preparation of flavonoid derivatives with antioxidant potency by Katsoura, M.H., Polydera, A.C., Tsironis, L., Tselepis, A.D., Stamatis, H.

    Published in Journal of biotechnology (10-06-2006)
    “…Biocatalytic preparation of acylated derivatives of flavonoid glycosides was performed using various immobilized lipases in two different ionic liquids, namely…”
    Get full text
    Journal Article
  13. 13

    Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile by Filippatos, T.D, Tsimihodimos, V, Derdemezis, C.S, Gazi, I.F, Saougos, V, Mikhailidis, D.P, Tselepis, A.D, Elisaf, M.S

    “…Abstract Background and aims Visfatin is associated with atherosclerosis-related diseases. We assessed in non-diabetic individuals the association of plasma…”
    Get full text
    Journal Article
  14. 14

    Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2 ) activity in healthy obese women by Tzotzas, T, Filippatos, T.D, Triantos, A, Bruckert, E, Tselepis, A.D, Kiortsis, D.N

    “…Abstract Introduction Platelet-activating factor acetylhydrolase (PAF-AH or Lp-PLA2 ) is a Ca2+ -independent phospholipase A2 primarily associated in plasma…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20